Inactive Instrument

Luminex Corporation

Equities

LMNX

US55027E1029

Advanced Medical Equipment & Technology

Luminex Corporation Provides Revenue Guidance for the Second Quarter of 2020

July 08, 2020 at 07:00 am EDT

Luminex Corporation provided revenue Guidance for the second quarter of 2020. For the quarter, the company expects revenues of between $109 and $110 million, up more than 30% over the second quarter of 2019.

Latest news about Luminex Corporation

Cytek Biosciences, Inc. completed the acquisition of Flow Cytometry & Imaging business unit of Luminex Corporation for $44.9 million.	23-02-27	CI
Transcript : Cytek Biosciences, Inc., Luminex Corporation - M&A Call	23-02-13
Cytek Biosciences, Inc. entered into an agreement to acquire Flow Cytometry & Imaging business unit of Luminex Corporation for $46.5 million.	23-02-12	CI
Luminex Corporation(NasdaqGS:LMNX) dropped from S&P 600 Health Care	21-07-15	CI
Luminex Corporation(NasdaqGS:LMNX) dropped from S&P 1000	21-07-15	CI
Luminex Corporation(NasdaqGS:LMNX) dropped from S&P TMI Index	21-07-15	CI
Luminex Corporation(NasdaqGS:LMNX) dropped from S&P Global BMI Index	21-07-15	CI
Luminex Corporation(NasdaqGS:LMNX) dropped from S&P Composite 1500	21-07-15	CI
Luminex Corporation(NasdaqGS:LMNX) dropped from S&P 600	21-07-15	CI
Luminex Corporation Announces Executive Changes	21-07-14	CI
Luminex Corporation(NasdaqGS:LMNX) dropped from NASDAQ Composite Index	21-07-14	CI
DiaSorin S.p.A. completed the acquisition of Luminex Corporation from BlackRock, Inc., Biomedical Advanced Research And Development Authority, The Vanguard Group, Inc., RGM Capital, LLC and others.	21-07-13	CI
Update: Middlesex Water to Replace Luminex in S&P SmallCap 600 -- Shares Jump in Pre-Market Trading	21-07-13	MT
Middlesex Water : to Replace Luminex in S&P SmallCap 600	21-07-13	MT
Luminex Corporation(NasdaqGS:LMNX) dropped from NASDAQ Biotechnology Index	21-07-13	CI
Middlesex Water : S&P Dow Jones Indices Says Middlesex Water Company (MSEX) to Replace Luminex (LMNX) in S&P SmallCap 600 from July 15	21-07-12	MT
Luminex : Gets US Regulatory Approval for Acquisition by DiaSorin	21-07-09	MT
Luminex : Quarterly Dividend Unchanged at $0.10 Per Share, Payable July 8 to Stockholders of Record on June 17	21-05-20	MT
Luminex Corporation Declared Cash Dividend for the Second Quarter of 2021, Payable on July 8, 2021	21-05-20	CI
Luminex Corporation Reports Earnings Results for the First Quarter Ended March 31, 2021	21-05-05	CI
LUMINEX : Piper Sandler Downgrades Luminex to Neutral From Overweight; Price Target is $37	21-04-13	MT
LUMINEX : BTIG Downgrades Luminex to Neutral From Buy	21-04-13	MT
Sector Update: Health Care Stocks Slip as Midday Gains Evaporate	21-04-12	MT
Sector Update: Health Care Stocks Drifting Higher This Afternoon	21-04-12	MT
Sector Update: Health Care	21-04-12	MT

Chart Luminex Corporation

Duration

Period

More charts

Company Profile

Luminex Corporation is a United States-based company that is a biotechnology company. The Company is involved in developing, manufacturing and marketing biological testing technologies in the clinical diagnostic and life science industries. Its offer a solution applicable in the markets, including clinical diagnostics, pharmaceutical drug discovery, genomic and proteomic research, biomedical research and food safety.

Sector

Advanced Medical Equipment & Technology

More about the company

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
THERMO FISHER SCIENTIFIC	+12.06%	227B
DANAHER CORPORATION	+12.07%	192B
INTUITIVE SURGICAL, INC.	+13.88%	136B
BOSTON SCIENTIFIC CORPORATION	+27.12%	108B
SIEMENS HEALTHINEERS AG	+0.91%	64.07B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	+6.74%	51.87B
EDWARDS LIFESCIENCES CORPORATION	+13.39%	52.1B
AGILENT TECHNOLOGIES, INC.	+8.81%	44.33B
GE HEALTHCARE TECHNOLOGIES INC.	+4.14%	36.75B

Other Advanced Medical Equipment & Technology